Skip to main content
Displaying 1 - 12 of 26
Display:
12
24
48
Metabolism, Alcohol & Toxicity
Novo Nordisk: "Walking the clinical care pathway for NASH: learnings from implementation" (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
Novo Nordisk and Echosens: "Clinical challenge: Updates on the non-invasive toolbox for NASH and Fibrosis" (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
Navigating MASH patient care
Webcasts
View
Metabolism, Alcohol & Toxicity
Novo Nordisk: Navigating MASH patient care (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
Q&A and closing remarks
Webcasts
View
Metabolism, Alcohol & Toxicity
Welcome and Introduction
Webcasts
View
Metabolism, Alcohol & Toxicity
Novo Nordisk: Unfolding the metabolic dysfunction of MASH: exploring the pathophysiology and outcomes (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
Linking the pathophysiology of MASH to its metabolic comorbidities
Webcasts
View
Metabolism, Alcohol & Toxicity
Approaching MASH as a metabolic disease to reduce outcomes
Webcasts
View
Metabolism, Alcohol & Toxicity
Panel Discussion (Q & A)
Webcasts
View
Metabolism, Alcohol & Toxicity
Welcome and introduction
Webcasts
View
Metabolism, Alcohol & Toxicity
Novo Nordisk:Clinical harmonisation for improving NASH diagnosis (Complete Session)
Webcasts
View
Pagination
Current page
1
Page
2
Page
3
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Privacy Policy
Cookie Policy